Promising Antileishmanial Activity of Micromeria nervosa Essential Oil: In Vitro and In Silico Studies
Molecules · 2024
DOI: 10.3390/molecules29081876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Rym Essid und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia. Hauptthemen laut MEDLINE: Oils, Volatile, Antiprotozoal Agents, Molecular Docking Simulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Researchers supporting project King Saud University, Riyadh, Saudi Arabia., King Saud University.
Abstract (Originalsprache)
The present study aimed to evaluate the leishmanicidal potential of the essential oil (EO) of Micromeria (M.) nervosa and to investigate its molecular mechanism of action by qPCR. Furthermore, in silicointeraction study of the major M. nervosa EO compounds with the enzyme cytochrome P450 sterol 14α-demethylase (CYP51) was also performed. M. nervosa EO was analyzed by gas chromatography-mass spectrometry (GC-MS). Results showed that α-pinene (26.44%), t-cadinol (26.27%), caryophyllene Oxide (7.73 ± 1.04%), and α-Cadinene (3.79 ± 0.12%) are the major compounds of M. nervosa EO. However, limited antioxidant activity was observed, as this EO was ineffective in neutralizing DPPH free radicals and in inhibiting β-carotene bleaching. Interestingly, it displayed effective leishmanicidal potential against promastigote (IC50 of 6.79 and 5.25 μg/mL) and amastigote (IC50 of 8.04 and 7.32 μg/mL) forms of leishmania (L.) infantum and L. major, respectively. Molecular mechanism investigation showed that M. nervosa EO displayed potent inhibition on the thiol regulatory pathway. Furthermore, a docking study of the main components of the EO with cytochrome P450 sterol 14α-demethylase (CYP51) enzyme revealed that t-cadinol exhibited the best binding energy values (−7.5 kcal/mol), followed by α-cadinene (−7.3 kcal/mol) and caryophyllene oxide (−7 kcal/mol). These values were notably higher than that of the conventional drug fluconazole showing weaker binding energy (−6.9 kcal/mol). These results suggest that M. nervosa EO could serve as a potent and promising candidate for the development of alternative antileishmanial agent in the treatment of leishmaniasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia.
- University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, Tunis 1068, Tunisia.
- Laboratory of Legumes and Sustainable Agro-Systems, Centre of Biotechnology of Borj Cedria, Hammam-Lif 2050, Tunisia.
- Center of Excellence in Biotechnology Research, College of Applied Medical Sciences, King Saud University, Riyadh 11495, Saudi Arabia.
- Department of Chemistry, College of Sciences and Health, Cleveland State University, Cleveland, OH 44115, USA.
ORCID-Profile: Rym Essid
Förderung
- Researchers supporting project King Saud University, Riyadh, Saudi Arabia.
- King Saud University
Zitieren
APA
Essid, R., Kefi, S., Damergi, B., Abid, G., Fares, N., Jallouli, S., Abid, I., Hussein, D., Tabbene, O., & Limam, F. (2024). Promising Antileishmanial Activity of Micromeria nervosa Essential Oil: In Vitro and In Silico Studies. Molecules. https://doi.org/10.3390/molecules29081876
Vancouver
Essid R, Kefi S, Damergi B, Abid G, Fares N, Jallouli S, et al. Promising Antileishmanial Activity of Micromeria nervosa Essential Oil: In Vitro and In Silico Studies. Molecules. 2024. doi:10.3390/molecules29081876
BibTeX
@article{Essid2024,
author = {Essid, Rym and Kefi, Sarra and Damergi, Bilel and Abid, Ghassen and Fares, Nadia and Jallouli, Selim and Abid, Islem and Hussein, Dina and Tabbene, Olfa and Limam, Ferid},
title = {Promising Antileishmanial Activity of Micromeria nervosa Essential Oil: In Vitro and In Silico Studies},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29081876}
}
EUVIMED